INTRODUCTION
The diamine putrescine and the polyamines spermidine and spermine are ubiquitous organic cations, which are indispensable for cell growth and differentiation. The two rate-limiting enzymes for polyamine biosynthesis are ornithine decarboxylase (ODC ; EC 4.1.1.17) and S-adenosylmethionine decarboxylase (AdoMetDC ; EC 4.1.1.50) [1] . ODC decarboxylates -ornithine to yield putrescine, the precursor of spermidine and spermine. The AdoMetDC produces decarboxylated S-adenosylmethionine. This serves as a donor of propylamine moieties, which are ligated to putrescine to form spermidine, and to spermidine to yield spermine. These reactions are carried out by spermidine synthase and spermine synthase, respectively [2] . ODC and AdoMetDC occur as two separate proteins in all organisms investigated so far. However, it was recently discovered in our laboratory that, in Plasmodium falciparum, both enzymes are linked to form one bifunctional ODC\AdoMetDC. The N-terminal AdoMetDC domain is joined to the C-terminal ODC domain by a hinge region [3] .
P. falciparum is the causative agent of severe malaria. Resistance against the anti-malarial drugs used today is developing and spreading rapidly. For this reason, there is an urgent need to identify new compounds that attack novel targets in the parasite's metabolism [4] .
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Inhibition of polyamine metabolism is known to have antitumour and anti-parasitic effects [5, 6] . The specific ODC inhibitor α-difluoromethylornithine (DFMO) is used as a trypanocidal drug against African sleeping sickness [7, 8] . DFMO has also been reported to affect Plasmodia in itro and in i o [9] [10] [11] . Apart from DFMO, a series of analogues of 3-amino-oxy-1-propanamine have been reported to potently inhibit ODC. They were active against human T #% bladder carcinoma both in itro and in i o [12, 13] .
We have cloned and recombinantly expressed the ODC domain of the bifunctional ODC\AdoMetDC. Two different constructs were expressed. The first comprises the P. falciparum ODC (Pf ODC) domain only. The second consists of the Pf ODC domain in addition to the preceding part of the hinge region of the bifunctional ODC\AdoMetDC. We analysed the catalytic properties of both recombinant proteins. Furthermore, we tested DFMO and two 3-amino-oxy-1-propanamine analogues for their potential as inhibitors of the Pf ODC domain.
EXPERIMENTAL Material
-Ornithine was purchased from Sigma (Deisenhofen, Germany). Putrescine was a product of Fluka (Neu-Ulm, Germany), -[1-"%C]ornithine (57 mCi:mmol V ") of Amersham-Buchler (Braunschweig, Germany). DFMO was a gift from MarionMerrel-Dow (Cincinnati, OH, U.S.A.). Ni# + -nitrilotriacetate (Ni-NTA) agarose was obtained from Qiagen (Hilden, Germany). The StrepTactin2 resin and anhydrotetracycline were purchased from the Institut fu$ r Bioanalytik (Go$ ttingen, Germany). The CGP series of ODC inhibitors was synthesized by Novartis (Basel, Switzerland) [12, 13] .
Cloning of the PfODC domain
The ODC domain of the bifunctional ODC\AdoMetDC of P. falciparum was determined by alignment of the deduced amino acid sequence with the amino acid sequences of the ODCs of various organisms. The domain comprises the amino acids methionine 805 to tryptophan 1419 [3] . We constructed two expression plasmids. (i) The first was the ODC domain alone (bp 2413-4257 of the coding region of the bifunctional ODC\ AdoMetDC) cloned into the expression plasmid pJC40 [14] . This expression construct was termed pJC40-Pf ODC. (ii) Second, the ODC domain and the additional 432 bp of the hinge region of the bifunctional ODC\AdoMetDC were cloned into the expression plasmid pASK-IBA7 (Institut fu$ r Bioanalytik). This expression construct comprised the bp 1981-4257 of the coding region of ODC\AdoMetDC. It was termed pASK-IBA7-Pf ODC.
To obtain pJC40-Pf ODC, the coding region of the ODC domain was amplified by PCR with Pfu polymerase using genomic DNA of P. falciparum FCBR strain as a template and the sense primer 5h-GCGCGAATTCATGGAAAAGAATTA-TAAAGAAGAAATATGG-3h and the antisense primer 5h-GCGCGGATCCTTACCAATGTTTGTTTGGTTGCCCC-3h. The underlined nucleotides indicate restriction sites for EcoRI in the sense primer and BamHI in the antisense primer. The PCR product was gel-purified and subcloned into the plasmid pBSj (Stratagene) by cyclic restriction ligation. The resulting construct was transformed into Escherichia coli DH5α. Recombinant plasmid DNA was isolated and digested with EcoRI and BamHI. The insert was gel-purified and subcloned into EcoRI\ BamHI-digested pJC40.
Compared with pJC40-Pf ODC, the insert in pASK-IBA7-Pf ODC was extended at its 5h end by 432 bp of the ODC\ AdoMetDC hinge region. We amplified bp 1981-4257 of the coding region of ODC\AdoMetDC by PCR using the sense primer 5h-GCGCGCGGTCTCCGCGCATGGAATATG-AAGAAAAAGATGAAGTGTATCGAAGG-3h, the antisense primer 5h-GCGCGCGGTCTCGTATCATTACCAATGTTTG-TTTGGT-TGCCCC-3h, Pfu DNA polymerase and genomic DNA of the P. falciparum FCBR strain as a template. The restriction sites for BsaI (New England Biolabs) are underlined in the primer sequences. The PCR product was gel-purified and digested with BsaI. It was then ligated into BsaI-digested pASK-IBA7.
Both expression plasmids were sequenced to ensure that the inserts were in the correct reading frame. Sequencing methods used were the Sanger dideoxy chain-termination method on double-stranded DNA [15] and terminator cycle sequencing using AmpliTaq DNA polymerase (Applied Biosystems) on an ABI Prism TM automatic sequencer.
Expression and purification of recombinant PfODC
pJC40-Pf ODC was transformed into E. coli BL21 (DE3) pLys. A single colony was picked and grown overnight at 37 mC in terrific broth medium supplemented with 50 µg\ml ampicillin [16] . Expression was carried out in a 2 litre high-density fermenter. The overnight culture (40 ml) was added to 1.5 litres of terrific broth supplemented with 50 µg\ml ampicillin. The cultures were grown at 37 mC to a D '!! of 1.5. Subsequently, 500 ml of terrific broth medium, 50 µg\ml ampicillin and 1 mM isopropyl β--thiogalactoside were added to the cultures. The incubation temperature was reduced to 30 mC. Cells were harvested 4 h after induction by centrifugation (4000 g ; 10 min). The bacterial pellet was resuspended in binding buffer (20 mM Tris\HCl, pH 7.9, containing 5 mM imidazole, 500 mM NaCl and 0.1 mM PMSF) and sonicated. The cell lysate was centrifuged at 100 000 g and 4 mC for 1 h. pJC40 encodes for an N-terminal His tag. The recombinant protein rPf ODC was purified by chelating chromatography on Ni-NTA agarose (Qiagen) according to the manufacturer's recommendations.
pASK-IBA7-Pf ODC was transformed into E. coli BL21-CodonPlus TM (DE3)-RIL (Stratagene). A single colony was picked and grown overnight in Luria-Bertani medium supplemented with 50 µg\ml ampicillin and 0.35 µg\ml chloramphenicol. The bacterial culture was diluted 1 : 50 and incubated at 37 mC until the D '!! reached 0.5. Expression was induced with 200 ng\ml anhydrotetracycline. Bacteria were grown for an additional 4 h at 30 mC before being harvested. The bacterial pellet was resuspended in 100 mM Tris\HCl buffer, pH 8.0, containing 1 mM EDTA, sonicated and then centrifuged at 100 000 g for 1 h at 4 mC. The recombinant Pf ODC with the partial hinge region (rPf Hinge-ODC) was purified using StrepTactin2 resin according to the manufacturer's recommendations.
The eluants from both constructs of recombinant Pf ODC were dialysed separately against 50 mM Tris\HCl buffer, pH 7.5, containing 1 mM dithiothreitol, 1 mM EDTA, 0.02 % Brij-35 and 0.1 mM PMSF. Protein was determined by the method of Bradford [17] , using BSA as a standard. The homogeneity of the enzyme preparation was analysed by SDS\PAGE. The proteins were revealed by Coomassie Brilliant Blue staining [16] . Recombinant expression and purification of the bifunctional ODC\ AdoMetDC of P. falciparum was carried out as described previously [3] .
N-terminal amino acid sequence of rPfODC
After purification, the eluant containing rPf ODC was separated by SDS\PAGE, electrotransferred to a ProBlot TM membrane (Applied Biosystems) and stained with Coomassie Brilliant Blue. The band corresponding to the rPf ODC (74 kDa) was excised and subjected to automated Edman degradation (Protein Sequencer 473A, Applied Biosystems).
Enzyme assay
Enzyme activity was assayed by measuring the production of "%CO # from -[1-"%C]ornithine at 37 mC as described previously [18] . The standard assay contained, in a final volume of 250 µl, 50 mM potassium phosphate buffer, pH 7.5, 1 mM dithiothreitol, 1 mM EDTA, 40 µM pyridoxal 5-phosphate, 0.02 % Brij-35, 100 µM ornithine (0.27 µCi of -[1-"%C]ornithine) and 75 nM rPf Hinge-ODC, 160 nM rPf ODC or 72 nM recombinant ODC\ AdoMetDC. The reaction time was 30 min. K m values of the recombinant Pf ODC domains were determined by varying the concentration of the non-radioactive ornithine in the standard assay. The inhibition constants for putrescine, CGP54619A and CGP52622A were determined under standard assay conditions with varying concentrations of ornithine and the addition of various concentrations of inhibitors. The K m value and the K i value for putrescine were calculated by Lineweaver-Burk plots using the software GraphPad Prism 1.0 (GraphPad Software). The K i values of the tight-binding inhibitors CGP54619A and CGP52622A were calculated from the Morrison equation [19] . The K i value for the irreversible inhibitor DFMO was determined by preincubation of aliquots of the rPf Hinge-ODC at 37 mC with various concentrations of DFMO. At different time points, samples were withdrawn and assayed for residual enzyme activity. Kinetic analysis of the inhibition was carried out according to the method of Kitz and Wilson [20] . The inhibitory effect of spermidine on both recombinant Pf ODC domains and of putrescine on the rPf ODC was determined under standard assay conditions, adding different concentrations of spermidine and putrescine, respectively. The IC &! values of rPf Hinge-ODC for putrescine, CGP54619A and CGP52622A were calculated from the equation
RESULTS AND DISCUSSION

Cloning and expression of the recombinant PfODC domain
The ODC domain of P. falciparum is part of the bifunctional ODC\AdoMetDC [3] . Such an arrangement of the two key enzymes in polyamine synthesis has, to date, not been detected in any other organism. However, P. falciparum possesses other bifunctional proteins. In its folate metabolism, the dihydrofolate reductase is joined to the thymidylate synthase (DHFR-TS), and the dihydropteroate synthase is combined with the dihydro-6-hydroxymethylpterin pyrophosphokinase [21, 22] . Moreover, in two membrane proteins an ATPase domain is combined with a guanylate cyclase domain [23] .
We expressed the Pf ODC domain in two different forms. In the pJC40-Pf ODC construct, we merely included the ODC domain of the bifunctional protein as it was defined by Mu$ ller et al. [3] . The recombinant Pf ODC domain was termed rPf ODC and contained an N-terminal His tag to facilitate purification. The pASK-IBA7-Pf ODC construct carried the Pf ODC domain and in addition the preceding part of the hinge region at its 5h end. The recombinant protein was termed rPf Hinge-ODC and carried an N-terminal Strep tag (Figure 1) . rPf ODC and rPf Hinge-ODC were purified by affinity chromatography on Ni-NTA agarose and StrepTactin2 resin, respectively, and 1 litre of bacterial culture yielded about 500 µg of rPf ODC or 150 µg of rPf Hinge-ODC. The purity of the enzyme preparations was assessed by SDS\PAGE ( Figure 2 ). The band representing the putative recombinant rPf ODC was subjected to N-terminal amino acid sequencing, which confirmed the presence of the recombinant protein (results not shown). Western blotting with antiserum against rPf ODC identified the bands running below 
Figure 2 SDS/PAGE analyses of the rPfODC (I) and rPfHinge-ODC (II)
The recombinant proteins migrated to 71 and 88 kDa, respectively. Bands migrating below them were considered products of degradation. Protein was revealed by Coomassie Brilliant Blue staining.
the recombinant proteins as products of degradation (results not shown). The rPf ODC has a subunit molecular mass of 74.3 kDa. (71.3 kDa Pf ODC domain and 3 kDa His tag). The rPf Hinge-ODC, which includes 144 amino acids of the hinge region, has a molecular mass of 87.9 kDa (including 1.5 kDa Strep tag). The Pf ODC domain is substantially larger than most eukaryotic ODCs, which vary in their molecular mass between 43 and 55 kDa [18, [24] [25] [26] [27] [28] [29] . This is due to two large insertions in the Pf ODC domain, which interrupt the regions of homology [3] . The ODC of Leishmania dono ani is even larger than the Pf ODC domain because it possesses an N-terminal extension [30] . However, this extension does not bear any homology to the hinge region of the P. falciparum ODC\AdoMetDC [3] . Although the overall homology between the Pf ODC domain and the mammalian ODC is only 21 %, the residues that are essential for dimerization and catalytic activity of the mammalian ODC are conserved in the Pf ODC domain [3] .
Enzyme activity
Both forms of Pf ODC that we expressed are dependent on pyridoxal 5-phosphate, which is the essential coenzyme of ODCs [31] . Maximum specific activity of the recombinant Pf ODC domains is obtained at pyridoxal 5-phosphate concentrations of 10 µM and above for the rPf Hinge-ODC and 50 µM and above for the rPf ODC in the standard assay. Optimal activity is obtained at pH values of 7.0-8.0 for the rPf ODC and pH 7.5-8.5 for the rPf Hinge-ODC. The pH optimum reported for mammalian ODC is in the range of 7.0-7.8 [31] . Both Pf ODCs were stabilized by the addition of 0.02 % Brij-35. This feature was also reported for highly purified mammalian ODC [31] . Freezing leads to a complete loss of activity of the recombinant Pf ODC domains. The differential sensitivity to pyridoxal 5-phosphate and the different pH optima warrant the conclusion that there are distinctions between the catalytic features of the two recombinant Pf ODC domains. Analysing the enzyme activities in more detail, this becomes even more obvious : the specific activity and k cat value of the rPf ODC are lower than those of the rPf Hinge- [24] . § Data from [36] .
ODC. The enzyme activity of the rPf Hinge-ODC is linear with time and enzyme concentration for up to 40 min of incubation at 37 mC. The mean specific activity of the rPf Hinge-ODC is 4.3p0.54 nmol:min V ":mg V " (n l 4), resulting in k cat l 0.38 min V ". The rPf ODC has a maximum specific activity of 2.9 nmol:min V ":mg V " and its k cat is 0.2 min V ". More importantly, the K m value of the rPf ODC for the substrate -ornithine is significantly higher than the K m value of the rPf Hinge-ODC. The K m value of the rPf Hinge-ODC is 47.3p10.9 µM (n l 4), which is comparable with that of the Pf ODC domain in the native bifunctional protein (K m l 42.4 µM) [3] . This K m value is similar to those of the monofunctional proteins of mammals [24, 32] . Compared with the ODCs of other protozoa, however, the Pf ODC domain has a considerably higher affinity for its substrate [25, 29, 32] . The K m value of the rPf ODC for -ornithine is 161.5p61.8 µM (n l 4), which is about 3.5 times higher than the K m value of the rPf Hinge-ODC and the native Pf ODC domain.
We assessed the influence of their product, putrescine, on the activity of the recombinant Pf ODC domains. The K i value of the rPf Hinge-ODC for putrescine is 50.4p16.8 µM (n l 3), and the calculated IC &! value is 157 µM. Similar K i values were reported for the ODC of the nematode Panagrellus redi i us and a membrane-associated ODC of Caenorhabditis elegans [18, 33] . In contrast, the ODCs of mammals as well as of some lower eukaryotes are less sensitive to putrescine, the K i value for putrescine of the ODC from rat liver being 600 µM [24, 26, 29, 34] . Interestingly, the IC &! value of the rPf ODC for putrescine is 500 µM. This value is in line with the lower affinity for -ornithine of the rPf ODC as compared with the rPf Hinge-ODC. For a summary of the properties of the rPf Hinge-ODC, the rPf ODC and the mammalian ODC, see Table 1 . Furthermore, we tested the effect of spermidine on the recombinant Pf ODC domains. Spermidine is a weak inhibitor of both recombinant enzymes, and it affects them equally. In a standard assay, 1 mM spermidine reduced the activity of the rPf Hinge-ODC by 61 %, the activity of the rPf ODC by 63 % (n l 2). As far as we are aware, significant inhibition of ODC activity by spermidine has only been reported for the membrane-associated ODC of C. elegans [33] .
These results show that there are substantial catalytic differences between the rPf Hinge-ODC and the rPf ODC, whereas the K m value of the rPf Hinge-ODC is comparable with that of the native ODC domain in the bifunctional protein [3] . We therefore conclude that part of the hinge region of the bifunctional ODC\AdoMetDC is important for the catalytic activity of the Pf ODC domain. It is conceivable that the hinge region supports the correct folding of the Pf ODC domain.
We have separately cloned and recombinantly expressed the ODC domain and the AdoMetDC domain (T. Krause, K. Lu$ ersen, C. Wrenger, S. Mu$ ller and R. D. Walter, unpublished work) of the bifunctional P. falciparum ODC\AdoMetDC. Both domains are catalytically active, and surprisingly their catalytic features do not differ from those of the native bifunctional protein [3] . It is, therefore, unlikely that in the native bifunctional ODC\AdoMetDC the two domains exert any regulatory influence on each other. This is in contrast to the DHFR-TS of P. falciparum, which is a well-studied bifunctional protein. In the DHFR-TS an essential interaction between the two domains takes place, rendering it impossible to express a functional TS domain only [35] .
Inhibition of enzyme activity
The inhibitor studies were carried out with the rPf Hinge-ODC and, for comparison, with the recombinant bifunctional ODC\ AdoMetDC. The development of DFMO by Metcalf and colleagues in 1978 [36] constitutes a milestone in polyamine research. DFMO, a derivative of the amino acid ornithine, is a specific, so-called mechanism-based inhibitor of ODC. It leads to irreversible inhibition of the enzyme by an alkylation of its active centre. DFMO is an active trypanocidal agent, which cures patients with African sleeping sickness caused by Trypanosoma brucei gambiense even at late stages of the disease [8] . Moreover, DFMO blocks the erythrocytic schizogony of P. falciparum in culture and reduces the parasitaemia in Plasmodium bergheiinfected mice [9] [10] [11] .
We determined the K i for DFMO of the rPf Hinge-ODC as 87.6p14.3 µM (n l 3). The half-time of inactivation at saturating DFMO concentrations is 0.65p0.07 min (n l 3 ; Figure  3 ). In comparison, mouse ODC has a K i for DFMO of only 39 µM [36] . However, the K i of the T. brucei brucei ODC for DFMO is 220 µM, and its half-time of inactivation is 2.7 min [37] . The differential effect of DFMO on trypanosomes as compared with mammalian cells can be explained by three factors. First, the parasites are rapidly dividing cells, and as such have a higher requirement for polyamines than the host cells. Secondly, trypanosomes use spermidine to synthesize trypanothione, which is essential for the maintenance of their intracellular redox state [38] . Thirdly, the ODC of T. brucei has a longer half life than the mammalian ODC, because it lacks a PEST sequence which leads to rapid intracellular degradation of the mammalian enzyme [2, 28] . This argument can partly be applied to Plasmodia : they are also rapidly proliferating cells. The ODC of P. falciparum was reported to be relatively stable [9] , although its C-terminus resembles a PEST region [3] .
A few years ago, a series of highly potent ODC inhibitors was synthesized. The compounds are analogues of 3-amino-oxy-1-propanamine [12, 13] . Members of this group of ODC inhibitors were reported to inhibit rat liver ODC with an IC &! in the nanomolar range. They are active against the growth of human T #% bladder carcinoma cells in itro, and some compounds are tumoristatic in mice bearing solid T #% tumours. The cellular growth arrest appears to be due to polyamine depletion, because it is reversed by spermidine. Furthermore, cells resistant to 3-amino-oxy-2-fluoro-1-propanamine have amplified ODC genes [12, 13] . CGP52622A, which belongs to this series, is a reversible inhibitor of the Pf ODC. It inhibits the rPf Hinge-ODC with a K i value of 20.4p8.1 nM (n l 3). The calculated IC &! value is 63.5 nM, which is comparable with that of the recombinant bifunctional ODC\AdoMetDC (31.7p2.8 nM, n l 3). The inhibitory effect of the second compound which we tested, CGP54619A, is even more pronounced. It reversibly inhibits the rPf Hinge-ODC with a K i value of 7.9p2.1 nM (n l 3). Again, the calculated IC &! value of 25 nM fits well with the IC &! value determined for the recombinant ODC\AdoMetDC (18.6p1.3 nM, n l 3). In view of the extremely low K i values, we propose that CGP52622A and CGP54619A should be further evaluated as possible anti-malarial agents.
In summary, we have cloned, recombinantly expressed and kinetically characterized the ODC domain of the bifunctional ODC\AdoMetDC in two forms. The catalytic differences between the recombinant Pf ODC domain that includes part of the hinge region, and the recombinant Pf ODC domain without the hinge region, imply that the hinge region is important for correct folding and activity of the Pf ODC domain. Interestingly, the recombinant rPf Hinge-ODC has catalytic properties comparable with the native Pf ODC domain. We have tested inhibitors of ODC against this recombinant domain, and identified CGP52622A and CGP54619A as highly effective compounds. They should be assessed for their potential as anti-malarial drugs.
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